163 related articles for article (PubMed ID: 34295164)
1. The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition.
Du W; Liu X; Yang M; Wang W; Sun J
Onco Targets Ther; 2021; 14():4223-4229. PubMed ID: 34295164
[TBL] [Abstract][Full Text] [Related]
2. Paired-related homeobox 1 induces epithelial-mesenchymal transition in oesophageal squamous cancer.
Guo JB; Du M; Wang B; Zhong L; Fu ZX; Wei JL
World J Gastrointest Oncol; 2023 Dec; 15(12):2185-2196. PubMed ID: 38173429
[TBL] [Abstract][Full Text] [Related]
3. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
4. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
5. PRRX1 isoform PRRX1A regulates the stemness phenotype and epithelial-mesenchymal transition (EMT) of cancer stem-like cells (CSCs) derived from non-small cell lung cancer (NSCLC).
Sun L; Han T; Zhang X; Liu X; Li P; Shao M; Dong S; Li W
Transl Lung Cancer Res; 2020 Jun; 9(3):731-744. PubMed ID: 32676335
[TBL] [Abstract][Full Text] [Related]
6. Loss of PRRX1 induces epithelial-mesenchymal transition and cancer stem cell-like properties in A549 cells.
Zhu H; Sun G
Am J Transl Res; 2017; 9(4):1641-1650. PubMed ID: 28469771
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid synthase contributes to epithelial-mesenchymal transition and invasion of salivary adenoid cystic carcinoma through PRRX1/Wnt/β-catenin pathway.
Zhang WL; Wang SS; Jiang YP; Liu Y; Yu XH; Wu JB; Wang K; Pang X; Liao P; Liang XH; Tang YL
J Cell Mol Med; 2020 Oct; 24(19):11465-11476. PubMed ID: 32820613
[TBL] [Abstract][Full Text] [Related]
8. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.
Jiang J; Zheng M; Zhang M; Yang X; Li L; Wang SS; Wu JS; Yu XH; Wu JB; Pang X; Tang YJ; Tang YL; Liang XH
Neoplasia; 2019 Feb; 21(2):216-229. PubMed ID: 30622052
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.
Fan M; Shen J; Liu H; Wen Z; Yang J; Yang P; Liu K; Chang Y; Duan J; Lu K
Oncol Rep; 2017 Aug; 38(2):1083-1090. PubMed ID: 28677793
[TBL] [Abstract][Full Text] [Related]
10. HSP27 associates with epithelial-mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma.
Chen W; Ren X; Wu J; Gao X; Cen X; Wang S; Sheng S; Chen Q; Tang YJ; Liang XH; Tang YL
J Cell Mol Med; 2018 Apr; 22(4):2283-2298. PubMed ID: 29424489
[TBL] [Abstract][Full Text] [Related]
11. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
[TBL] [Abstract][Full Text] [Related]
12. PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells.
Dong J; Lv Z; Chen Q; Wang X; Li F
Int J Clin Exp Pathol; 2018; 11(5):2629-2635. PubMed ID: 31938377
[TBL] [Abstract][Full Text] [Related]
13. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
[TBL] [Abstract][Full Text] [Related]
14. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
15. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
16. Relationship between PRRX1, circulating tumor cells, and clinicopathological parameter in patients with gastric cancer.
Zhang Y; Yao J; Feng J; Wang S; Yang Z; Huang W; Da M
J BUON; 2020; 25(3):1455-1462. PubMed ID: 32862590
[TBL] [Abstract][Full Text] [Related]
17. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway.
Yang HF; Yu M; Jin HD; Yao JQ; Lu ZL; Yabasin IB; Yan Q; Wen QP
Front Physiol; 2017; 8():510. PubMed ID: 28798691
[TBL] [Abstract][Full Text] [Related]
20. Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.
Lv ZD; Yang ZC; Liu XP; Jin LY; Dong Q; Qu HL; Li FN; Kong B; Sun J; Zhao JJ; Wang HB
J Cell Mol Med; 2016 Sep; 20(9):1640-50. PubMed ID: 27027510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
